Novel 2D/3D Hybrid Organoid System for High-Throughput Drug Screening in iPSC Cardiomyocytes

Jordann Lewis,Basil Yaseen,Anita Saraf

DOI: https://doi.org/10.1101/2024.04.29.591754

2024-04-30

Abstract:Human induced pluripotent stem cell cardiomyocytes (hiPSC-CMs) allow for high-throughput evaluation of cardiomyocyte (CM) physiology in health and disease. While multimodality testing provides a large breadth of information related to electrophysiology, contractility, and intracellular signaling in small populations of iPSC-CMs, current technologies for analyzing these parameters are expensive and resource-intensive. We sought to design a 2D/3D hybrid organoid system and harness optical imaging techniques to assess electromechanical properties, calcium dynamics, and signal propagation across CMs in a high-throughput manner. We validated our methods using a doxorubicin-based system, as the drug has well-characterized cardiotoxic, pro-arrhythmic effects. hiPSCs were differentiated into CMs, assembled into organoids, and thereafter treated with doxorubicin. The organoids were then replated to form a hybrid 2D/3D iPSC-CM construct where the 3D cardiac organoids acted as the source of electromechanical activity which propagated outwards into a 2D iPSC-CM sheet. The organoid recapitulated cardiac structure and connectivity, while 2D CMs facilitated analysis at an individual cellular level which recreated numerous doxorubicin-induced electrophysiologic and propagation abnormalities. Thus, we have developed a novel 2D/3D hybrid organoid model that employs an integrated optical analysis platform to provide a reliable high-throughput method for studying cardiotoxicity, providing valuable data on calcium, contractility, and signal propagation.

Cell Biology

What problem does this paper attempt to address?

### Problems the paper attempts to solve

The paper aims to address the limitations of current drug - screening methods in evaluating cardiotoxicity (especially arrhythmia and abnormal calcium handling). Specifically, the researchers developed a novel 2D/3D hybrid organoid system to enable high - throughput drug screening of human - induced pluripotent stem cell - derived cardiomyocytes (hiPSC - CMs). The following are the specific problems the paper attempts to solve:

1. **Limitations of existing technologies**:
- **2D cell culture**: Although 2D cell culture can quickly and simply study the structure and function of cardiomyocytes, they cannot fully simulate the complexity of cardiac tissue and lack cell - cell interactions.
- **3D organoid model**: Although the 3D organoid model can better reflect the morphology of cardiac tissue and the cell - cell communication network, there are still challenges in drug toxicity screening in the 3D environment, such as the difficulty in isolating single cells from 3D spherical cell aggregates for analysis.

2. **Requirement for high - throughput screening**:
- Currently, techniques for analyzing the electrophysiological properties, contractility, and intracellular signal transduction of cardiomyocytes (such as patch - clamp technique and microelectrode array) are expensive and resource - intensive, making it difficult to achieve high - throughput screening.
- Optical analysis methods (such as calcium transient imaging) are widely accepted, but may be affected by optical signal interference when applied in 3D organoids.

3. **Evaluation of drug cardiotoxicity**:
- Many drugs fail to reach relevant endpoints in pre - clinical and clinical tests and are ultimately withdrawn from the market due to off - target toxicity (such as cardiotoxicity).
- Cardiotoxicity is a particularly concerning issue because many drugs can affect cardiac function, leading to pathological conditions such as heart failure, cardiomyopathy, and arrhythmia.

To solve these problems, the researchers designed a hybrid organoid system that combines the advantages of 2D and 3D, and used optical imaging techniques to evaluate the electromechanical properties, calcium dynamics, and signal propagation of cardiomyocytes. In this way, they hope to provide a reliable and efficient high - throughput method to study the cardiotoxicity of drugs, especially those known to have cardiotoxic and pro - arrhythmic effects (such as doxorubicin).